Adverse Obstetric Outcomes in Pregnant Women Using Natalizumab for the Treatment of Multiple Sclerosis: A Systematic Review

Multiple sclerosis is a common disease in women of childbearing age, characterized by demyelination of the central nervous system. Among the different treatment options available, disease-modifying therapies (DMTs) are the most efficacious, and natalizumab (NAT) is an injectable DMT best for relapsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramesh, Vaiishnavi, Opara, Collins O, Khan, Farhana Yaqoob, Kabiraj, Gargi, Kauser, Humaira, Palakeel, Jaimee J, Ali, Mazin, Chaduvula, Phani, Chhabra, Sanika, Lamsal Lamichhane, Smriti, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635932/
https://www.ncbi.nlm.nih.gov/pubmed/36381897
http://dx.doi.org/10.7759/cureus.29952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635932/
https://www.ncbi.nlm.nih.gov/pubmed/36381897
http://dx.doi.org/10.7759/cureus.29952

Ejemplares similares